Harashima S-I, Ogura M, Tanaka D, et al
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
doi:10.2147/DMSO.S271160 91
In a notable study involving 141 participants, including both children and adults with autism, supplement use led to significant improvements in metabolic biomarkers such as sulfate, glutathione, SAM, ATP, and NADH, which are essential for cellular energy and antioxidant defenses
Benefits Before Surgery: Energy Production: Enhances cellular energy, keeping you feeling strong and balanced
It is not manufactured by or affiliated with Eli Lilly or any other brand manufacturer of GIP+GLP-1 medications